Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Carrier screening is a blood or saliva test that reveals whether you and your partner carry gene variants for inherited conditions like cystic fibrosis, spinal muscular atrophy, sickle cell disease, or Tay-Sachs, even when neither of you has symptoms. Most of these conditions are recessive, meaning a child is at risk primarily when both parents carry a variant in the same gene, which is why testing both partners before conception gives the clearest picture. Ideal timing, panel size, ethnicity-based versus expanded screening, and what a positive result means for options like IVF with genetic testing or donor gametes are all factors to consider, and see below to understand the important details. If you are also noticing symptoms such as irregular cycles, unexplained fatigue, or difficulty conceiving while planning ahead, sorting out what is routine and what deserves a doctor's attention can be hard on your own. Take a free, instant, online symptom check to better understand what your body may be signaling and to get clear guidance on the next steps to discuss with your provider.
Last reviewed for medical accuracy: 08/18/2026
Carrier screening is a simple set of genetic tests designed to identify whether you carry changes (variants) in certain genes that could be passed on to a child. Understanding your carrier status before pregnancy helps you make informed choices about family planning, supports early preparation and reduces uncertainty down the road.
Carrier screening looks for gene changes that may not affect your own health but could lead to a genetic condition in your child if both parents carry the same variant. Key points:
Early knowledge of carrier status lets you:
By planning ahead, you reduce surprises and gain more control over your family’s future.
Most expanded carrier screening panels test for dozens of conditions. These often include:
Each lab offers different panels; ask your provider which conditions they include.
Hypophosphatasia (HPP) is a rare inherited disorder that affects bone and tooth development. Key facts:
Understanding your Hypophosphatasia carrier risk pregnancy is vital if HPP runs in your family or if your ancestry increases your likelihood of carrying ALPL variants.
To estimate your risk:
If both partners carry a recessive ALPL variant, each pregnancy has a:
Pre-test Counseling
Sample Collection
Results Review
Results typically fall into three categories:
Next steps may include partner testing, further family testing or specialized counseling.
If both partners share a risk gene, options include:
A genetic counselor can help weigh the benefits and challenges of each path.
Understanding your personal health is as important as genetic risk assessment. You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you track potential concerns and decide if you need professional evaluation.
Carrier screening empowers you with information—never a guarantee—but a roadmap. No matter your results:
Always speak to a doctor about anything that could be life threatening or serious. If you have concerns about symptoms, family history, or carrier screening, a healthcare professional can provide personalized advice and support.
(References)
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Prior TW, Leach ME, Finanger EL. Spinal Muscular Atrophy. 1993. PMID: 20301526.
* Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, Sheth V, Woodward JE, Peckham HE, Schroth GP, Kim RW, Kingsmore SF. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med. 2011 Jan 12;3(65):65ra4. doi: 10.1126/scitranslmed.3001756. PMID: 21228398; PMCID: PMC3740116.
* Committee Opinion No. 691: Carrier Screening for Genetic Conditions. Obstet Gynecol. 2017 Mar;129(3):e41-e55. doi: 10.1097/AOG.0000000000001952. PMID: 28225426.
* King JR, Klugman S. Ethnicity-Based Carrier Screening. Obstet Gynecol Clin North Am. 2018 Mar;45(1):83-101. doi: 10.1016/j.ogc.2017.10.010. PMID: 29428288.
* Zhao S, Xiang J, Fan C, Asan, Shang X, Zhang X, Chen Y, Zhu B, Cai W, Chen S, Cai R, Guo X, Zhang C, Zhou Y, Huang S, Liu Y, Chen B, Yan S, Chen Y, Ding H, Guo F, Wang Y, Zhong W, Zhu Y, Wang Y, Chen C, Li Y, Huang H, Mao M, Yin Y, Wang J, Yang H, Xu X, Sun J, Peng Z. Pilot study of expanded carrier screening for 11 recessive diseases in China: results from 10,476 ethnically diverse couples. Eur J Hum Genet. 2019 Feb;27(2):254-262. doi: 10.1038/s41431-018-0253-9. Epub 2018 Oct 1. PMID: 30275481; PMCID: PMC6336873.
* Capalbo A, Valero RA, Jimenez-Almazan J, Pardo PM, Fabiani M, Jiménez D, Simon C, Rodriguez JM. Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes. PLoS Genet. 2019 Oct;15(10):e1008409. doi: 10.1371/journal.pgen.1008409. Epub 2019 Oct 7. PMID: 31589614; PMCID: PMC6797235.
* Gregg AR, Aarabi M, Klugman S, Leach NT, Bashford MT, Goldwaser T, Chen E, Sparks TN, Reddi HV, Rajkovic A, Dungan JS, ACMG Professional Practice and Guidelines Committee. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 Oct;23(10):1793-1806. doi: 10.1038/s41436-021-01203-z. Epub 2021 Jul 20. PMID: 34285390; PMCID: PMC8488021.
* Harteveld CL, Achour A, Arkesteijn SJG, Ter Huurne J, Verschuren M, Bhagwandien-Bisoen S, Schaap R, Vijfhuizen L, El Idrissi H, Koopmann TT. The hemoglobinopathies, molecular disease mechanisms and diagnostics. Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):28-36. doi: 10.1111/ijlh.13885. PMID: 36074711; PMCID: PMC9542123.
* Cornel MC, van der Meij KRM, van El CG, Rigter T, Henneman L. Genetic Screening-Emerging Issues. Genes (Basel). 2024 May 3;15(5). doi: 10.3390/genes15050581. Epub 2024 May 3. PMID: 38790210; PMCID: PMC11121342.
* Kirk EP, Delatycki MB, Archibald AD, Tutty E, Caruana J, Halliday JL, Lewis S, McClaren BJ, Newson AJ, Dive L, Best S, Long JC, Braithwaite J, Downes MJ, Scuffham PA, Massie J, Barlow-Stewart K, Kulkarni A, Ruscigno A, Kanga-Parabia A, Rodrigues B, Bennetts BH, Ebzery C, Hunt C, Cliffe CC, Lee C, Azmanov D, King EA, Madelli EO, Zhang F, Ho G, Danos I, Liebelt J, Fletcher J, Kennedy J, Beilby J, Emery JD, McGaughran J, Marum JE, Scarff K, Fisk K, Harrison K, Boggs K, Giameos L, Fitzgerald L, Thomas L, Burnett L, Freeman L, Harris M, Berbic M, Davis MR, Cifuentes Ochoa M, Wallis M, Wall M, Chow MTM, Ferrie MM, Pachter N, Quayum N, Lang N, Kasi Pandy P, Casella R, Allcock RJN, Ong R, Edwards S, Sundercombe S, Jelenich S, Righetti S, Lunke S, Kaur S, Stock-Myer S, Eggers S, Walker SP, Theodorou T, Catchpool T, Clinch T, Roscioli T, Hardy T, Zhu Y, Fehlberg Z, Boughtwood TF, Laing NG, Mackenzie’s Mission Investigators, Mackenzie's Mission Investigators. Nationwide, Couple-Based Genetic Carrier Screening. N Engl J Med. 2024 Nov 21;391(20):1877-1889. doi: 10.1056/NEJMoa2314768. PMID: 39565987.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.